We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Problems Surface in US Plan to Vaccinate for Smallpox

By Biotechdaily staff writers
Posted on 04 Feb 2003
Following an announcement by the US government that voluntary vaccinations of health care workers against smallpox would begin this month, concerns and objections are arising from many of those scheduled for inoculation.

The first phase of the vaccination program calls for up to 500,000 health care workers to be vaccinated in the coming weeks. More...
A later, second phase would include first responders such as police, firefighters, and emergency medical personnel. However, many of those scheduled to be vaccinated have refused and many health care workers are voicing concerns and questions.

One concern is the safety of the vaccine. When the vaccine was last used in the 1960s, there were two deaths and 52 life-threatening complications for every million people who were vaccinated. The vaccine employs the vaccinia virus, which is related to smallpox. There is a possibility that the virus may shed from the site of inoculation and infect others. This could be dangerous to those who are especially vulnerable, such as babies and people who have compromised immune systems. One important question raised is if a vaccinated health care worker has a bad reaction and cannot work for a number of days, who will pay for that time? Still another problem is the cost of the program. Many healthcare workers say the government is seriously underestimating the costs of the program, which also have to include training, screening out people at risk, following up on people with bad reactions, and managing the data from the program.

As a result, many of the hospitals and medical centers that had scheduled vaccinations are now reporting they are delaying any further involvement in the program until they have more information and can answer everyone's concerns.

"At this time, our highest priority is to vaccinate members of smallpox response teams in the states,” said Dr. Julie Gerberding, director of the US Centers for Disease Control and Prevention (CDA, Atlanta, GA, USA). "Several months of detailed planning and training, and the development of scientifically sound and informative educational materials have prepared us for the safe and rapid implementation of the plan to vaccinate those health care professionals who would be on the front lines in the event of a smallpox attack.”




Related Links:
US Centers for Disease Control and Prevention (CDC)

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Silver Member
Connectivity Solution
EKF Link
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.